DOCSLIB.ORG

Annual Report and Financial Statements 2019 a Nnu Al R Eport an D F in an Cial S Tatem Ents 2019

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annual Report and Financial Statements 2019 a Nnu Al R Eport an D F in an Cial S Tatem Ents 2019 Annual Report and Financial Statements 2019 Annual Report and Financial Statements 2019 RELX is a global provider of information-based analytics and decision tools for professional and business customers. We help scientists make new discoveries, doctors and nurses improve the lives of patients and lawyers win cases. We prevent online fraud and money laundering, and help insurance companies evaluate and predict risk. Our events enable customers to learn about markets, source products and complete transactions. In short, we enable our customers to make better decisions, get better results and be more productive. Forward-looking statements This Annual Report contains forward-looking statements within the meaning of Section 27A of the US Securities Act of 1933, as amended, and Section 21E of the US Securities Exchange Act of 1934, as amended. These statements are subject to risks and uncertainties that could cause actual results or outcomes of RELX PLC (together with its subsidiaries, “RELX”, “we” or “our”) to differ materially from those expressed in any forward-looking statement. The terms “outlook”, “estimate”, “project”, “plan”, “intend”, “expect”, “should”, “will”, “believe”, “trends” and similar expressions may indicate a forward-looking statement. Important factors that could cause actual results or outcomes to differ materially from estimates or forecasts contained in the forward-looking statements include, among others, current and future economic, political and market forces; changes in law and legal interpretations affecting RELX intellectual property rights and internet communications; regulatory and other changes regarding the collection, transfer or use of third-party content and data; demand for RELX products and services; competitive factors in the industries in which RELX operates; ability to realise the future anticipated benefits of acquisitions; significant failure or interruption of our systems; compromises of our data security systems or other unauthorised access to our databases; legislative, fiscal, tax and regulatory developments and political risks; exchange rate fluctuations; and other risks referenced from time to time in the filings of RELX PLC with the US Securities and Exchange Commission. RELX Annual report and financial statements 2019 1 Overview* Overview Contents 2 2019 Financial highlights 3 Chair’s statement 4 Chief Executive Officer’s report 5 RELX business overview Market segments* 12 Scientific, Technical & Medical 18 Risk & Business Analytics 24 Legal 30 Exhibitions segmentsMarket Corporate Responsibility* 37 Corporate Responsibility overview Financial review* 52 Chief Financial Officer’s report 58 Principal and emerging risks Governance 64 Board Directors Corporate Responsibility 66 RELX Senior Executives 68 Chair’s introduction to corporate governance 70 Corporate governance review 85 Report of the Nominations Committee 88 Directors’ remuneration report 112 Report of the Audit Committee 115 Directors’ report Financial statements and other information Financial review 120 Independent auditor’s report 128 Consolidated financial statements 177 RELX PLC annual report and financial statements 182 Summary financial information in euros 183 Summary financial information in US dollars 184 Reconciliation of adjusted to GAAP measures 186 Shareholder information IBC 2020 financial calendar * Comprises the Strategic Report in accordance with The (UK) Companies Act 2006 (Strategic Report and Directors’ Report) Regulations 2013. Governance other information other statementsFinancial and Get more information online A PDF of the full Annual Report and further information about our businesses can be found online at our website: www.relx.com 2 RELX Annual report and financial statements 2019 | Overview 2019 Financial highlights § Underlying revenue growth of 4% § Underlying adjusted operating profit growth of 5% § Reported operating profit £2,101m (£1,964m) § Adjusted EPS at constant currency up 7%; in sterling up 10% to 93.0p § Reported EPS 77.4p (71.9p) § Full-year dividend up 9% to 45.7p § Strong financial position and cash flow; cash flow conversion at 96% RELX financial summary REPORTED FIGURES Change at 2019 2018 constant Change For the year ended 31 December £m £m Change currencies underlying Revenue 7,874 7,492 +5% +2% +4% Operating profit 2,101 1,964 +7% Profit before tax 1,847 1,720 +7% Net profit attributable to RELX PLC shareholders 1,505 1,422 +6% Net margin 19.1% 19.0% Net borrowings 6,191 6,177 Reported earnings per share 77.4p 71.9p +8% Ordinary dividend per RELX PLC share 45.7p 42.1p +9% ADJUSTED FIGURES Change at 2019 2018 constant Change For the year ended 31 December £m £m Change currencies underlying Operating profit 2,491 2,346 +6% +3% +5% Operating margin 31.6% 31.3% Profit before tax 2,200 2,145 +3% 0% Net profit attributable to RELX PLC shareholders 1,808 1,674 +8% +5% Net margin 23.0% 22.3% Cash flow 2,402 2,243 +7% Cash flow conversion 96% 96% Return on invested capital 13.6% 13.2% Adjusted earnings per share 93.0p 84.7p +10% +7% The shares of RELX PLC are traded on the London, Amsterdam and New York stock exchanges. RELX PLC and its subsidiaries, joint ventures and associates are together known as ‘RELX’. RELX uses adjusted and underlying figures as additional performance measures. Adjusted figures primarily exclude the amortisation of acquired intangible assets and other items related to acquisitions and disposals, and the associated deferred tax movements. In 2018, we excluded exceptional tax credits, see note 9 on page 145. Reconciliations between the reported and adjusted figures are set out on page 184. Underlying growth rates are calculated at constant currencies, excluding the results of acquisitions until twelve months after purchase, and excluding the results of disposals and assets held for sale. Underlying revenue growth rates also exclude exhibition cycling. Constant currency growth rates are based on 2018 full-year average and hedge exchange rates. RELX Annual report and financial statements 2019 3 Chair’s statement Overview made great progress over the past decade and is well positioned for future growth. As a result, I believe that this is the year both from my own perspective and from that of the company in which to make a change of Chair. At the 2019 Annual General Meeting, Ben van der Veer stood down from the Board after nine years’ service, Carol Mills, a segmentsMarket Non-Executive director since 2016 left the Board, and Andrew Sukawaty was appointed a Non-Executive Director. Andrew has had a 30-year career in the telecoms industry, he is Chairman of Inmarsat and was a Non-Executive Director of Sky between 2013 and 2018. In December Charlotte Hogg was appointed a Non-Executive Director. Ms Hogg is currently Executive Vice President and Chief Executive Officer for the European operations of Visa, a Board Director of Visa Europe and a member of Visa’s global executive committee. In 2020, Suzanne Wood will take over from Adrian Hennah as Chair of the Audit Committee. Adrian, Sir Anthony Habgood who has been on the Board since 2011, will be stepping down as a Corporate Responsibility Chair Non-Executive Director after the next Annual General Meeting. I would like to thank Ben, Adrian and Carol for their support and advice, We continued to execute well on and am delighted that Andrew and Charlotte have joined the Board. our strategic priorities in 2019. Stakeholder consultation We conducted our biennial survey to understand what matters This was reflected in strong to different stakeholders: we asked investors, customers, employees, suppliers, and representatives from government and earnings. We also continued to build non-governmental organisations among others, to rank the issues they believe have the biggest impact on RELX. The top two issues on our strong environmental, social were having the right people and data privacy and security. We also asked them to identify where we have the biggest impact on society Financial review and governance performance and the environment – our unique contributions as a business during the year, and this was again came first, followed by access to information. Corporate responsibility recognised in the high ratings given to Corporate responsibility (CR) has been a priority at RELX for many years. The Board of Directors regularly takes time to engage on the us by a number of external agencies. subject, overseeing our CR objectives and performance, ensuring we are operating at the highest commercial and ethical standards. RELX continued to execute well on its strategic priorities aimed at Our belief remains firmly that good governance and sustainability achieving more predictable revenues, a higher growth profile and are integral to good financial performance. improving returns. Underlying revenue growth was again 4%, with We believe that CR is a core strength of RELX and it is significant underlying adjusted operating profits up 5%, as we continued to Governance grow revenues ahead of costs. Adjusted earnings per share grew that Environmental, Social and Governance (ESG) performance 10% in sterling to 93.0p (84.7p), and 7% at constant currencies. is increasingly being recognised as an important indicator of a Reported earnings per share were 77.4p (71.9p). company’s overall health, the sustainability of its market positions, its attractiveness to key employees and its ability to generate Dividends growing long-term returns to shareholders. As a company with a We are proposing a full year dividend increase of 9% to 45.7p. long-standing record of leadership in this broad field, RELX is now The long-term dividend policy is unchanged. benefitting from the greater profile that is being given to ESG and Balance sheet the increasingly rigorous and objective ways in which it is being Net debt was £6.2bn at 31 December 2019, unchanged from last measured, monitored and indexed. In 2019 RELX was ranked year. Net debt/EBITDA including pensions and leases was 2.5x, second in the S&P Global 1200 for ESG performance by CSRHub, compared with 2.4x in 2018.
Load more

Recommended publications
  • 2013--Annual-Report-Accounts.Pdf
    Helping people make measurable progress in their lives through learning ANNUAL REPORT AND ACCOUNTS 2013 OUR TRANSFORMATION To find out more about how we are transforming our business go to page 09 EFFICACY To find out more about our focus on efficacy go to page 14 OUR PERFORMANCE For an in-depth analysis of our performance in 2013 go to page 19 Pearson is the world’s leading learning company, with 40,000 employees in more than 80 countries working to help people of all ages to make measurable progress in their lives through learning. We provide learning materials, technologies, assessments and services to teachers and students in order to help people everywhere aim higher and fulfil their true potential. We put the learner at the centre of everything we do. READ OUR REPORT ONLINE Learn more www.pearson.com/ar2013.html/ar2013.html To stay up to date wwithith PPearsonearson throughout the year,r, visit ouourr blog at blog.pearson.comn.com and follow us on Twitteritter – @pearsonplc 01 Heading one OVERVIEW Overview 02 Financial highlights A summary of who we are and what 04 Chairman’s introduction 1 we do, including performance highlights, 06 Our business models our business strategy and key areas of 09 Chief executive’s strategic overview investment and focus. 14 Pearson’s commitment to efficacy OUR PERFORMANCE OUR Our performance 19 Our performance An in-depth analysis of how we 20 Outlook 2014 2 performed in 2013, the outlook 23 Education: North America, International, Professional for 2014 and the principal risks and 32 Financial Times Group uncertainties affecting our businesses.
    [Show full text]
  • Tissue and Cell
    TISSUE AND CELL AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Impact Factor p.1 • Abstracting and Indexing p.1 • Editorial Board p.1 • Guide for Authors p.3 ISSN: 0040-8166 DESCRIPTION . Tissue and Cell is devoted to original research on the organization of cells, subcellular and extracellular components at all levels, including the grouping and interrelations of cells in tissues and organs. The journal encourages submission of ultrastructural studies that provide novel insights into structure, function and physiology of cells and tissues, in health and disease. Bioengineering and stem cells studies focused on the description of morphological and/or histological data are also welcomed. Studies investigating the effect of compounds and/or substances on structure of cells and tissues are generally outside the scope of this journal. For consideration, studies should contain a clear rationale on the use of (a) given substance(s), have a compelling morphological and structural focus and present novel incremental findings from previous literature. IMPACT FACTOR . 2020: 2.466 © Clarivate Analytics Journal Citation Reports 2021 ABSTRACTING AND INDEXING . Scopus PubMed/Medline Cambridge Scientific Abstracts Current Awareness in Biological Sciences Current Contents - Life Sciences Embase Embase Science Citation Index Web of Science EDITORIAL BOARD . Editor Pietro Lupetti, University of Siena, Siena, Italy AUTHOR INFORMATION PACK 1 Oct 2021 www.elsevier.com/locate/tice 1 Managing Editor Giacomo Spinsanti, University of Siena,
    [Show full text]
  • Orthopaedic Bioengineering Research Laboratory 2010-2011
    2010-2011 Report including the Orthopaedic Bioengineering Research Laboratory Preface It is my pleasure to present our 2010-2011 report been possible without a number of our donors from the Orthopaedic Research Center and the stepping up to provide supplemental funding. Orthopaedic Bioengineering Research Laboratory I’m particularly grateful to Mr. Jim Kennedy for at Colorado State University. Our principal focus providing supplemental operating funds and continues to be solving the significant problems in continuing the legacy of his mother, Barbara Cox equine musculoskeletal disease as can be seen in this Anthony. I’m also grateful to Abigail Kawananakoa report but we also continue to investigate questions for continued support over and above the Endowed relevant to human joint disease and techniques Chair she donated three years ago; and Herbert Allen and devices for human osteoarthritis and articular for continuing to provide considerable support for cartilage repair when the technique can also benefit investigation of cutting edge therapies. the horse. There have been a number of notable projects in this regard. The studies, led by Dr. Dave We have added an Equine Sports Medicine Frisbie at the ORC in partnership with Dr. Alan Ambulatory clinical arm to the Orthopaedic Research Grodzinsky at MIT on an NIH Program Grant in Center and also initiated two residencies in Sports cartilage repair, have been completed and results Medicine and Rehabilitation. This follows on from are still be analyzed. We have three other ongoing the accreditation of a new specialty college, the NIH grants in partnership with collaborators. One is American College of Veterinary Sports Medicine and with Dr.
    [Show full text]
  • Announcement
    Announcement Total 100 articles, created at 2016-06-09 18:04 1 Best mobile games of 2016 (pictures) Looking for a new game to play on your mobile device? Here's our pick of the best released in 2016 (so far). 2016-06-09 12:53 677Bytes (1.08/2) www.cnet.com 2 Apple revamps App Store, may not win over developers Apple Inc. announced a series of long-awaited enhancements to (1.05/2) its App Store on Wednesday, but the new features may not ease concerns of developers and analysts who say that the App Store model - and the very idea of the single-purpose app - has... 2016-06-09 08:46 4KB pctechmag.com 3 HPE Unveils Converged Systems for IoT The Edgeline EL1000 and EL4000 systems are part of a larger series of announcements by HPE to address such IoT issues as (1.02/2) security and management. 2016-06-09 12:49 5KB www.eweek.com 4 What is AmazonFresh? Amazon launches new grocery service for the UK: Can I get (1.02/2) AmazonFresh in the UK? What is AmazonFresh, Amazon launches new grocery service for the UK, Can I get AmazonFresh in the UK, where does AmazonFresh deliver, what does AmazonFresh deliver 2016-06-09 12:42 3KB www.pcadvisor.co.uk 5 Borderlands 3 UK release date, price and gamelplay rumours: Gearbox has confirmed the (1.02/2) game is being developed Gearbox, the developers behind the Borderlands series are back it again with a new game on the horizon. 2016-06-09 11:00 3KB www.pcadvisor.co.uk 6 More Than 32 Million Twitter Passwords May Have Been Hacked And Leaked On The Dark (1.02/2) Web Last week Facebook’s CEO Mark Zuckerberg's social accounts; Pinterest and Twitter were briefly hacked, with the details coming from the LinkedIn breach that happened in 2012, with the founder of the world’s biggest social network reusing the password “dadada.” This time around Twitter users have become the..
    [Show full text]
  • Rb-Annual-Report-2012.Pdf
    Reckitt Benckiser Group plc Reckitt Benckiser Group Healthier Happier Annual Report and Financial Statements 2012 Stronger Reckitt Benckiser Group plc Annual Report and Financial Statements 2012 Contents 1 Chairman’s Statement 2 Chief Executive’s Statement 10 Business Review 2012 18 Board of Directors and Executive Committee 19 Report of the Directors 22 Chairman’s Statement on Corporate Governance 24 Corporate Governance Report 30 Statement of Directors’ Responsibilities 31 Directors’ Remuneration Report 38 Independent Auditors’ Report to the members of Reckitt Benckiser Group plc 39 Group income statement 39 Group statement of comprehensive income 40 Group balance sheet 41 Group statement of changes in equity 42 Group cash flow statement 43 Notes to the financial statements 75 Five-year summary 76 Parent Company – Independent Auditors’ Report to the members of Reckitt Benckiser Group plc 77 Parent Company balance sheet 78 Notes to the Parent Company financial statements 84 Shareholder information Chairman’s Statement largest consumer health care category in The Board conducted its regular reviews the world with the acquisition of Schiff of the Company’s brands, geographic area Nutrition International, Inc. (Schiff) and and functional performance together with its leading US brands in the vitamins, detailed reviews of its human resources. minerals and supplements market. There The Board also completed its annual were also a few disposals of non core assessment of corporate governance assets. Net debt at the end of 2012, after including Board performance, corporate paying for dividends, net acquisitions and responsibility, and reputational and organisation restructuring, stood at business risk. £2,426m (2011: £1,795m). AGM Resolutions Your Board proposes an increase in the final The resolutions, which will be voted dividend of +11%, taking it to 78p per upon at our AGM of 2 May 2013 are share, and bringing the total dividend for fully explained in the Notice of Meeting.
    [Show full text]
  • Altmetric.Com and Plumx
    This is a preprint of an article published in Scientometrics. The final authenticated version is available online at: https://doi.org/10.1007/s11192-021-03941-y A large-scale comparison of coverage and mentions captured by the two altmetric aggregators- Altmetric.com and PlumX Mousumi Karmakara, Sumit Kumar Banshalb, Vivek Kumar Singha,1 1Department of Computer Science, Banaras Hindu University, Varanasi-221005, India 2Department of Computer Science, South Asian University, New Delhi-110021, India. Abstract: The increased social media attention to scholarly articles has resulted in creation of platforms & services to track the social media transactions around them. Altmetric.com and PlumX are two such popular altmetric aggregators. Scholarly articles get mentions in different social platforms (such as Twitter, Blog, Facebook) and academic social networks (such as Mendeley, Academia and ResearchGate). The aggregators track activity and events in social media and academic social networks and provide the coverage and transaction data to researchers for various purposes. Some previous studies have compared different altmetric aggregators and found differences in the coverage and mentions captured by them. This paper attempts to revisit the question by doing a large-scale analysis of altmetric mentions captured by the two aggregators, for a set 1,785,149 publication records from Web of Science. Results obtained show that PlumX tracks more altmetric sources and captures altmetric events for a larger number of articles as compared to Altmetric.com. However, the coverage and average mentions of the two aggregators, for the same set of articles, vary across different platforms, with Altmetric.com recording higher mentions in Twitter and Blog, and PlumX recording higher mentions in Facebook and Mendeley.
    [Show full text]
  • RELX Group Annual Reports and Financial Statements 2015
    Annual Reports and Financial Statements 2015 Annual Reports and Financial Statements 2015 RELX Group is a world-leading provider of information and analytics for professional and business customers across industries. We help scientists make new discoveries, lawyers win cases, doctors save lives and insurance companies offer customers lower prices. We save taxpayers and consumers money by preventing fraud and help executives forge commercial relationships with their clients. In short, we enable our customers to make better decisions, get better results and be more productive. RELX PLC is a London listed holding company which owns 52.9 percent of RELX Group. RELX NV is an Amsterdam listed holding company which owns 47.1 percent of RELX Group. Forward-looking statements The Reports and Financial Statements 2015 contain forward-looking statements within the meaning of Section 27A of the US Securities Act of 1933, as amended, and Section 21E of the US Securities Exchange Act of 1934, as amended. These statements are subject to a number of risks and uncertainties that could cause actual results or outcomes to differ materially from those currently being anticipated. The terms “estimate”, “project”, “plan”, “intend”, “expect”, “should be”, “will be”, “believe”, “trends” and similar expressions identify forward-looking statements. Factors which may cause future outcomes to differ from those foreseen in forward-looking statements include, but are not limited to competitive factors in the industries in which the Group operates; demand for the Group’s products and services; exchange rate fluctuations; general economic and business conditions; legislative, fiscal, tax and regulatory developments and political risks; the availability of third-party content and data; breaches of our data security systems and interruptions in our information technology systems; changes in law and legal interpretations affecting the Group’s intellectual property rights and other risks referenced from time to time in the filings of the Group with the US Securities and Exchange Commission.
    [Show full text]
  • Using Open Access Literature to Guide Full-Text Query Formulation Heather A
    Using open access literature to guide full-text query formulation Heather A. Piwowar and Wendy W. Chapman Background Much scientific knowledge is contained in the details of the full-text biomedical literature. Most research in automated retrieval presupposes that the target literature can be downloaded and preprocessed prior to query. Unfortunately, this is not a practical or maintainable option for most users due to licensing restrictions, website terms of use, and sheer volume. Scientific article full-text is increasingly queriable through portals such as PubMed Central, Highwire Press, Scirus, and Google Scholar. However, because these portals only support very basic Boolean queries and full text is so expressive, formulating an effective query is a difficult task for users. We propose improving the formulation of full-text queries by using the open access literature as a proxy for the literature to be searched. We evaluated the feasibility of this approach by building a high-precision query for identifying studies that perform gene expression microarray experiments. Methodology and Results We built decision rules from unigram and bigram features of the open access literature. Minor syntax modifications were needed to translate the decision rules into the query languages of PubMed Central, Highwire Press, and Google Scholar. We mapped all retrieval results to PubMed identifiers and considered our query results as the union of retrieved articles across all portals. Compared to our reference standard, the derived full- text query found 56% (95% confidence interval, 52% to 61%) of intended studies, and 90% (86% to 93%) of studies identified by the full-text search met the reference standard criteria.
    [Show full text]
  • May Your Drug Price Be Evergreen
    Journal of Law and the Biosciences, 590–647 doi:10.1093/jlb/lsy022 Advance Access Publication 7 December 2018 Original Article May your drug price be evergreen ∗,1 Robin Feldman Downloaded from https://academic.oup.com/jlb/article/5/3/590/5232981 by Elsevier user on 30 October 2020 Hastings College of the Law, University of California, 200 McAllister St. San Francisco, CA 94102, USA Corresponding author. E-mail: [email protected] ABSTRACT Presenting the first comprehensive study of evergreening, this article ex- amines the extent to which evergreening behavior—which can be defined as artificially extending the protection cliff—may contribute to theprob- lem. The author analyses all drugs on the market between 2005 and 2015, combing through 60,000 data points to examine every instance in which a company added a new patent or exclusivity. The results show a startling departure from the classic conceptualization of intellectual property pro- tection for pharmaceuticals. Rather than creating new medicines, pharma- ceutical companies are largely recycling and repurposing old ones. Specifi- cally, 78% of the drugs associated with new patents were not new drugs, but ∗ Robin Feldman is the Arthur J. Goldberg Distinguished Professor of Law and Director of the Institute for Innovation Law at the University of California Hastings. Her most recent books in the life sciences are Drug Wars (Cambridge) and Rethinking Patent Law (Harvard). Professor Feldman also has published more than 50 articles in law journals including at Harvard, Yale, and Stanford, as well as in the American Economic Review and the New England Journal of Medicine. Professor Feldman’s empirical work has been cited by the White House and numerous federal agencies.
    [Show full text]
  • Enriching Chemistry Database Content with Human-Like Indexing of Documents
    WHITE PAPER Enriching Chemistry Database Content with Human-Like Indexing Of Documents APPLYING THE POWER OF A TAXONOMY WITH 450 MILLION TERMS Taxonomies are used to index content in databases, making facts and literature discoverable. The size of some taxonomies can make this task daunting. A comprehensive taxonomy to describe chemistry uses roughly 450 million terms, making it ~450 times the size of the English language and ~150 times the size of the next nearest discipline-specific taxonomy. To ensure that Reaxys® fully facilitates discoverability in the far-reaching and complex discipline of chemistry, two processes occur alongside each other: the familiar manual indexing and excerption method; and a novel automatic but human-like indexing process. How can the content in a large and diverse database be made highly discoverable? The English language has over 1 million words. How many do you think the average person can recognize? The online survey TestYourVocab.com enables visitors to test the size of their English vocabulary. The results reveal interesting trends. Data on roughly 450,000 native English speakers shows that most adult survey participants have a vocabulary size of 20,000 to 35,000 words. These are words that they can recognize and define. Topping the charts were individuals who came near 40,000 words. While these figures do not represent the average English-speaking population—it takes a certain type of person to respond to such surveys—and may be biased by the data collection methodology, the survey results hint at an upper limit to the word and concept retention capacity of the human brain.
    [Show full text]
  • Botanica Marina 2017 · FEBRUARY · Volume 60 · Number 1 · PAGES 1–84
    Botanica MARINA 2017 · FEBRUARY · VOLUME 60 · NUMBER 1 · PAGES 1–84 EDITOR-IN-CHIEF Matthew J. Dring, Belfast/Portaferry, Northern Ireland (–2020) ASSOCIATE EDITORS Kirsten Heimann, Townsville, Australia (–2020) Ka-Lai Pang, Keelung, Taiwan (–2020) Georg Pohnert, Jena, Germany (–2017) Michel Poulin, Ottawa, Canada (–2020) EDITORIAL BOARD Charles D. Amsler, Birmingham, USA (–2020) Inka Bartsch, Bremerhaven, Germany (−2018) John Beardall, Clayton, Australia (–2017) John A. Berges, Milwaukee, USA (–2020) Sung Min Boo, Daejeon, Korea (–2018) Olivier De Clerck, Ghent, Belgium (–2018) Jeffrey L. Gaeckle, Olympia, USA (−2018) Mona Hoppenrath, Wilhelmshaven, Germany (–2018) Catriona Hurd, Hobart, Australia (−2018) Gavin W. Maneveldt, Bellville, South Africa (–2018) Michael J. Wynne, Ann Arbor, USA (–2020) Abstracted/INDEXED IN AGRICOLA (National Agricultural Library); Baidu Scholar; Cabell’s Directory; CABI (over 50 subsections); Celdes; Chemical Abstracts Service (CAS) - CAplus; Chemical Abstracts Service (CAS) - SciFinder; CNKI Scholar (China National Knowledge Infrastructure); CNPIEC; EBSCO (relevant databases); EBSCO Discovery Service; Elsevier - BIOBASE/CABS (Current Awareness in Biological Sciences); Elsevier - Fluidex; Elsevier - Geobase; Elsevier - Reaxys; Elsevier - SCOPUS; Gale/Cengage; Genamics JournalSeek; Google Scholar; J-Gate; JournalTOCs; KESLI-NDSL (Korean National Discovery for Science Leaders); Naviga (Softweco); NISC SA: Fish and Fisheries Worldwide; NISC SA: Water Resources Worldwide; Primo Central (ExLibris); ProQuest (relevant
    [Show full text]
  • Why Trade Show Executive?
    Winner of 43 editorial and design awards. WHY TRADE SHOW EXECUTIVE? 7% Trade Show Executive Convention Management reaches the prospects 7% you covet: Exhibition A BPA-Audited Staff Circulation of 5,000 54% (Source: , June 2018) Show 32% Management Executive Management EACH MONTH IN TRADE SHOW EXECUTIVE ANNUAL OVERVIEW AND MORE... 8% 2.3% 4% 1.0% 0% 0.1% POWER LUNCH TSE DASHBOARD (4)% SPONSORED BY (8)% Presents the Leading Shows (12)% m™ NSF Zo Exhibitors Coming Up in North America (16)% Attendees TSE’S TRADE SHOW CALENDAR Done Deals w BY CAROL ANDREWS, Editor-at-Large Trade Show Executive 2010 2011 2012 2013 2014 2015 2016 2017 2018 Dashboard Snapshot – CONSOLIDATED OVERVIEWS Whether you need a quick reminder industry category and contains both The of shows on the horizon or are a wide-angle and close-up view of QUARTERLY OVERVIEW Trade Show Executive studyingTrade Show the Executive market for potential the event, the organizer, the site and A monthly round-up of new and partnerships, co-locations or projected size. 8% DASHBOARD — FEBRUARY TRADE SHOW METRICS SPONSORED BY DASHBOARDacquisitions, here is a list of the most To be considered for future editions of SPONSORED BY 0.9% POWER LUNCH — SEPTEMBER TRADE SHOW METRICS 1.4% important trade shows scheduled for ZOOM, e-mail your show information to 4% 0.8% world’s January 2020. Each show is listed by [email protected]. 1.2% 0% (0.8)% BY JAMIE BARTOSCH Show Name/Management/Web Address Show Manager Show Dates Venue/City/State Projected Size (0.2)% (4)% Senior News Editor
    [Show full text]